Caspofungin is used for the treatment of invasive candidiasis in adult or paediatric patients.

Álso for the treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin B. Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.

Finally it is used for presumed fungal infections (such as Candida or Aspergillus) in febrile, neutropaenic adult or paediatric patients.

Active ingredient Pharmaceutical form Package Therapeutic target
  • Caspofungin
  • Powder for Concentrate for Solution for Infusion

  • 50mg/Vial

  • 70 mg/Vial

  • Antifungal

Other products in "International"